Department of Veterinary Physiology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea.
Br J Pharmacol. 2011 Aug;163(8):1707-20. doi: 10.1111/j.1476-5381.2011.01316.x.
BACKGROUND AND PURPOSE We recently demonstrated that activation of the spinal sigma-1 receptor induces mechanical and thermal hypersensitivity via calcium-dependent second messenger cascades and phosphorylation of the spinal NMDA receptor GluN1 subunit (pGluN1). Here we examined the role of NO in this process, as it plays a critical role in PKC-mediated calcium signalling and the potentiation of NMDA receptor function. EXPERIMENTAL APPROACH The effects of intrathecal (i.t.) pretreatment with nNOS inhibitors on PRE084 (sigma-1 receptor agonist)-induced pain were assessed in mice by use of mechanical allodynia and thermal hyperalgesia tests. Western blot analysis, immunoprecipitation and immunohistochemical techniques were used to determine effects of these treatments on spinal pGluN1-immunoreactive (ir) cells, whether PRE084 induces a time-dependent modification of nNOS activity in the dorsal horn, and if any changes in nNOS activity can be blocked by sigma-1 receptor, calcineurin or soluble guanylyl cyclase (sGC) inhibitors. KEY RESULTS PRE084, injected i.t., induced mechanical and thermal hypersensitivity, and increased the number of PKC- and PKA-dependent pGluN1-ir cells in spinal cord. This PRE084-induced hypersensitivity and increase in PKC-dependent pGluN1 expression were blocked by pretreatment with N(G) -nitro-L-arginine methyl ester (L-NAME) or 7-nitroindazole (7-NI). PRE084 also time-dependently decreased the ratio of phosphorylated nNOS (pnNOS) to nNOS expression and the number of spinal pnNOS-ir cells. This decrease in pnNOS was prevented by BD1047, a sigma-1 receptor antagonist and cyclosporin A, a calcineurin inhibitor, but not by a sGC inhibitor. CONCLUSIONS AND IMPLICATIONS Spinal sigma-1 receptor-induced sensitization is mediated by an increase in nNOS activity, which is associated with an NO-induced increase in PKC-dependent pGluN1 expression.
我们最近证明,通过钙依赖性第二信使级联反应和脊髓 NMDA 受体 GluN1 亚基(pGluN1)的磷酸化,激活脊髓 sigma-1 受体可诱导机械和热痛觉过敏。在这里,我们研究了 NO 在这个过程中的作用,因为它在 PKC 介导的钙信号和 NMDA 受体功能的增强中起着关键作用。
通过使用机械性触诱发痛和热痛觉过敏测试,在小鼠中评估鞘内(i.t.)预处理 nNOS 抑制剂对 PRE084(sigma-1 受体激动剂)诱导的疼痛的影响。使用 Western blot 分析、免疫沉淀和免疫组织化学技术,确定这些处理对脊髓 pGluN1-免疫反应性(ir)细胞的影响,PRE084 是否在背角诱导 nNOS 活性的时间依赖性修饰,以及 nNOS 活性的任何变化是否可以被 sigma-1 受体、钙调神经磷酸酶或可溶性鸟苷酸环化酶(sGC)抑制剂阻断。
PRE084 鞘内注射可诱导机械性和热痛觉过敏,并增加脊髓中 PKC 和 PKA 依赖性 pGluN1-ir 细胞的数量。这种 PRE084 诱导的过敏和 PKC 依赖性 pGluN1 表达的增加可通过 N(G)-硝基-L-精氨酸甲酯(L-NAME)或 7-硝基吲唑(7-NI)预处理来阻断。PRE084 还时间依赖性地降低了磷酸化 nNOS(pnNOS)与 nNOS 表达的比值和脊髓 pnNOS-ir 细胞的数量。这种 pnNOS 的减少可被 sigma-1 受体拮抗剂 BD1047 和钙调神经磷酸酶抑制剂环孢素 A 预防,但不能被 sGC 抑制剂预防。
脊髓 sigma-1 受体诱导的敏化作用是由 nNOS 活性的增加介导的,这与 NO 诱导的 PKC 依赖性 pGluN1 表达增加有关。